alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
|What's New · 
   What's Next · 
   Site Map · 
   A-Z Index ·
   Careers ·
   RSS ·
   All Videos ·
   Current FAQs ·
   Contact Us |  | Search  Advanced Search | 
|----------------------------------------------------------------------------------------------------------------------------------- |  | ----------------------- | 

Aboutthe Fed
    News& Events
    MonetaryPolicy
    BankingInformation& Regulation
    PaymentSystems
    EconomicResearch& Data
    Consumer Information
    CommunityDevelopment
    ReportingForms
    Publications


skip to content 
 Home Economic Research & Data Statistical Releases and Historical Data
 DDP Print
   Industrial Production and Capacity Utilization - G.17 Current Release
  Release Dates
  Monthly Supplement
  Annual Revision
  Data Download
  About
  Announcements
  Technical Q&As
 Current Release  (248 KB PDF)
(ASCII)  Table 9 Gross Value of Final Products and Nonindustrial Supplies  Item
2009
2013
2013Q4
2014
2014Q1[r]
Q2[r]
Feb.[r]
Mar.[r]
Apr.[r]
May[r]
June[r]
July[p]Final products and nonindustrialsupplies
3,212.1
3,626.4
3,683.0
3,715.4
3,744.5
3,730.6
3,750.1
3,751.8
3,745.3
3,736.5
3,785.6Final products
2,410.8
2,746.7
2,789.5
2,821.1
2,849.5
2,833.0
2,856.9
2,858.6
2,847.5
2,842.4
2,884.6Consumer goods
1,811.4
1,984.3
2,018.6
2,043.6
2,056.0
2,051.4
2,069.5
2,067.2
2,052.7
2,048.2
2,074.8Durable
381.7
523.5
541.9
538.3
553.7
544.1
548.2
547.6
555.4
558.1
594.3Automotive products
225.1
346.9
361.7
359.1
371.2
366.3
368.2
366.3
373.0
374.4
410.2Other durable goods
156.5
176.6
180.3
179.3
182.7
178.1
180.2
181.5
182.7
184.0
185.2Nondurable
1,429.8
1,474.1
1,492.2
1,518.9
1,518.5
1,521.7
1,535.7
1,533.9
1,514.0
1,507.5
1,504.4Equipment, total
599.4
769.0
777.1
783.3
800.7
787.6
793.4
798.0
802.3
801.9
818.2Business and defense
583.2
745.1
753.0
759.0
775.7
763.3
768.9
773.0
777.2
776.9
793.1Business
477.2
627.3
634.3
641.1
656.4
645.7
650.3
654.0
658.2
656.9
672.1Defense and space
106.0
118.2
119.1
118.4
119.9
118.2
119.2
119.6
119.7
120.5
121.7Nonindustrial supplies
801.3
879.4
893.2
894.0
894.6
897.3
892.8
892.7
897.4
893.7
900.5Construction supplies
221.8
260.6
264.2
264.6
266.8
265.0
266.8
263.7
267.6
269.3
271.2Business supplies
579.5
619.4
629.6
630.0
628.5
632.9
626.7
629.7
630.6
625.2
630.2Commercial energy products
233.3
241.7
247.4
246.5
240.4
248.6
240.4
243.1
241.1
237.1
239.9     Return to top
   Home Economic research and data
 Accessibility Contact Us Disclaimer  Linking Policy FOIA
 PDF Reader
BOVIE
      MEDICAL CORPORATION





EXHIBIT
      32.1





Certification
      Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In
      connection with the Quarterly Report of Bovie Medical Corporation (the
“Company”) on Form 10-QSB for the year ended June 30, 2006 as filed with the
      Securities and Exchange Commission on the date hereof, I, Andrew Makrides,
      President and Chairman of the Board of the Company, certify, pursuant to 18
      USC
§1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002,
      that
      (1) the quarterly report fully complies with the requirements of section 13(a)
      or 15(d) of the Securities Exchange Act of 1934; and (2) the information
      contained in the annual report fairly presents, in all material respects, the
      financial condition and results of operations of the Company.











Date:
      August 9, 2006











/s/
                Andrew MakridesPresident,
                ChiefExecutive
                Officer, Chairmanof
                the Board and Director





A
      signed
      original of this written statement required by Section 906 of the Sarbanes-Oxley
      Act has been provided to the Company and will be retained by the Company and
      furnished to the Securities and Exchange Commission or its staff upon
      request.

















BOVIE
      MEDICAL CORPORATION





EXHIBIT
      32.2













Certification
      Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In
      connection with the Quarterly Report of Bovie Medical Corporation (the
“Company”) on Form 10-QSB for the year ended June 30, 2006 as filed with the
      Securities and Exchange Commission on the date hereof, I, Andrew Makrides,
      Chief
      Financial Officer, certify, pursuant to 18 USC §1350 as adopted pursuant to
      section 906 of the Sarbanes-Oxley Act of 2002, that (1) the Annual Report fully
      complies with the requirements of section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and (2) the information contained in the quarterly report
      fairly presents, in all material respects, the financial condition and results
      of operations of the Company.








Date:
      August 9, 2005











/s/
                Andrew MakridesChief
                Financial Officer,








A
      signed
      original of this written statement required by Section 906 of the Sarbanes-Oxley
      Act has been provided to the Company and will be retained by the Company and
      furnished to the Securities and Exchange Commission or its staff upon
      request.
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 1 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 2 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 3 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 4 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 5 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 6 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 7 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 8 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 9 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 10 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 11 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 12 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 13 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 14 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 15 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 16 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 17 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 18 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 19 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 20 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 21 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 22 of 23
Case No. 1:11-cr-00355-MSK Document 236 filed 03/13/13 USDC Colorado pg 23 of 23
IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Criminal Case No. 11–cr–000335-001-MSK

UNITED STATES OF AMERICA,

Plaintiff,

v.

1. WAUNITA WEINGART,

Defendant.

Waunita Weingart, by and through her attorney, Martin Stuart of PortmanStuart, 

LLC, hereby files this Notice of Disposition, informing the Court of her intent and

request to the Court to change her plea from Not Guilty to Guilty. Defendant

respectfully requests that the Court set a Change of Plea hearing as expeditiously as 

the Court’s calendar permits

Respectfully submitted,

Dated:February 19, 2013 By: s/Martin Stuart_____ 

MARTIN STUART, counsel for Ms. 

Weingart

 PortmanStuart, LLC

955 Bannock Street, suite 200

 Denver, CO 80204

 Phone 303-355-6789

 Fax 303-623-0714

Case No. 1:11-cr-00355-MSK Document 220 filed 02/19/13 USDC Colorado pg 1 of 2
CERTIFICATE OF SERVICE

I hereby certify that on this 19th day of February 2013, I electronically filed the 

foregoing with the Clerk of the Court using the CM/ECF system which will send 

notification of such filing to the following e-mail addresses: 

Linda Kaufman

Martha Paluch

Assistant United States Attorneys

1225 17th St., Ste. 700

Denver, CO 80202

Linda.kaufman@usdoj.gov

William Taylor

Attorney or John Gallegos

303 16th Street, #200

Denver, CO 80202

wltaylorpc@gmail.com

Paula Ray

Attorney for Alois Craig Weingart

1801 Broadway, suite 1100

Denver, CO 80202

paulamray@earthlink.net

/s/ Martin Stuart________

Martin Stuart

Case No. 1:11-cr-00355-MSK Document 220 filed 02/19/13 USDC Colorado pg 2 of 2
Case No. 1:11-cr-00355-MSK Document 360 filed 01/14/14 USDC Colorado pg 1 of 6
Case No. 1:11-cr-00355-MSK Document 360 filed 01/14/14 USDC Colorado pg 2 of 6
Case No. 1:11-cr-00355-MSK Document 360 filed 01/14/14 USDC Colorado pg 3 of 6
Case No. 1:11-cr-00355-MSK Document 360 filed 01/14/14 USDC Colorado pg 4 of 6
Case No. 1:11-cr-00355-MSK Document 360 filed 01/14/14 USDC Colorado pg 5 of 6
Case No. 1:11-cr-00355-MSK Document 360 filed 01/14/14 USDC Colorado pg 6 of 6
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 1 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 2 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 3 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 4 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 5 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 6 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 7 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 8 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 9 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 10 of 11
Case 1:11-cr-00291-WJM Document 67 Filed 06/19/12 USDC Colorado Page 11 of 11
EXHIBIT 10.1




	


EXHIBIT 10.1



March 26, 2004



Dr. Phillip Frost

IVAX Corporation

4400 Biscayne Blvd.

Miami, Florida 33137










	 	RE: 	Renewal/Extension
of Loan to Continucare Corporation
(“Borrower”)






	


Dear Dr. Frost:



        Reference
is made to the Unconditional Guaranty (as the same has been reaffirmed, amended or
modified from time to  time, the “Guaranty”), dated as of March 9, 2000,
executed by you in favor of Merrill Lynch Business Financial Services  Inc. (“Lender”),
pursuant to which you guaranteed the repayment obligations of Borrower in connection with
the WCMA Loan  and Security Agreement, dated as of March 9, 2000, between Borrower and
Lender (as same has been amended, extended or  modified from time to time, the “Loan
Agreement”).  Borrower and Lender have negotiated an extension of the Loan Agreement
as set forth in the attached letter.



        Please
reaffirm, by executing this letter and returning it to the undersigned, that following
the extension of the  Loan Agreement as agreed by Borrower and Lender, your Guaranty will
remain in full force and effect.  By executing this  letter, you will also acknowledge
your agreement to further extend the term of your Guaranty for an additional period of
one-year beyond the proposed extended maturity date of the Loan Agreement if Borrower and
Lender shall agree on such a  further extension.  In consideration of your written
reaffirmation of the Guaranty, the Borrower shall issue to you 300,000  shares of the
Corporation’s common stock, $.0001 par value per share.










			Sincerely,


CONTINUCARE CORPORATION



By: /s/ Richard C. Pfenniger, Jr.

——————————————

Richard C. Pfenniger, Jr.

Chairman and Chief Executive Officer






	


CONFIRMATION:



The undersigned agrees to the
foregoing:






/s/ Dr. Phillip Frost

——————————————

Dr. Phillip Frost
EXHIBIT
32.2




CERTIFICATION




Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350, as
adopted), the undersigned, Mark R. Doede, President, Chief Operating Officer and
Chief Financial Officer of Integral Vision, Inc. (the “Company”), hereby certifies
that, to the best of his knowledge:




1.The
Company's Annual Report on Form 10-K for the year ended December 31, 2009
(the “Periodic
Report”), to which this Certification is attached as Exhibit 32.2,
fully complies with the requirements of Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934, as amended; and




2.The
information contained in the Periodic Report fairly presents, in all material
respects, the financial condition of the Company at the end of the period
covered by the Periodic Report and results of operations of the Company for the
period covered by the Periodic Report.




DATED: 
       April 29,
      2010/S/ Mark R. DoedeMark
      R. DoedePresident,
      Chief Operating Officer,and
      Chief Financial Officer
[Federal Register Volume 73, Number 193 (Friday, October 3, 2008)]
[Notices]
[Page 57625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-23383]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisition of Shares of Bank or 
Bank Holding Companies

    The notificants listed below have applied under the Change in Bank 
Control Act (12 U.S.C. 1817(j)) and Sec.  225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. 
The factors that are considered in acting on the notices are set forth 
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
    The notices are available for immediate inspection at the Federal 
Reserve Bank indicated. The notices also will be available for 
inspection at the office of the Board of Governors. Interested persons 
may express their views in writing to the Reserve Bank indicated for 
that notice or to the offices of the Board of Governors. Comments must 
be received not later than October 20, 2008.
    A. Federal Reserve Bank of Atlanta (Steve Foley, Vice President) 
1000 Peachtree Street, N.E., Atlanta, Georgia 30309:
    1. Mark Allen Conner, Canton, Georgia, to acquire additional voting 
shares of FirstCity Bancorp, Inc., and thereby indirectly acquire 
additional voting shares of FirstCity Bank, both of Stockbridge, 
Georgia.
    2. James C. Jones, Waycross, Georgia; Patrick C. Jones and Carole 
C. Jones, both of Blackshear, Georgia; to retain voting shares of Jones 
Bancshares, LP, and thereby indirectly retain voting shares of 
Primesouth Bank, both of Blackshear, Georgia.

    Board of Governors of the Federal Reserve System, September 30, 
2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8-23383 Filed 10-2-08; 8:45 am]
BILLING CODE 6210-01-S
#### Murray Altholtz, Plaintiff, *v.*Martin Altholtz, Defendant.

Supreme Court, Special Term, Kings County,

December 13, 1956.

*Carl V. Cafran*for plaintiff.

*David D. Rothbart*for defendant.

John E. Cone, J.

Plaintiff moves for judgment as demanded in the complaint, for an order of reference to assess damages and for an inquest on the ground that defendant has defaulted *648in answering the complaint. The defendant moves for a stay of all proceedings pending submission of the controversy to arbitration and for an order permitting defendant to serve a proposed answer. It appears that the defendant is technically in default for failure to timely serve an answer. However, it seems that a verbal extension of time was agreed upon by the respective attorneys, which the plaintiff insists upon disregarding. Although, by virtue of rule 4 of the Buies of Civil Practice an agreement between parties or their attorneys relating to any matter in an action is not binding unless in writing subscribed by the party, or by his attorney or counsel, upon the record herein there is a sufficient showing to justify an opening of such default. Accordingly, plaintiff’s motion is denied. Defendant’s default is opened and leave is granted to serve the proposed answer provided said answer is served within 15 days. Defendant’s cross motion to stay further proceedings after service of the proposed answer pending determination of arbitration proceedings as provided for in the agreement between the parties herein is granted. Settle orders on notice.
NOTE: This order is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

LEXMARK INTERNATIONAL, INC.,

Plaintiff-Cross-Appellant

v.

IMPRESSION PRODUCTS, INC.,

Defendant-Appellant

QUALITY CARTRIDGES, INC., JOHN DOES, 1-20, 

BLUE TRADING LLC, EXPRINT INTERNATIONAL,

INC., LD PRODUCTS, INC., PRINTRONIC 

CORPORATION, TESEN DEVELOPMENT (HONG 

KONG) CO. LTD., BENIGNO ADEVA AND HIS 

COMPANIES,

Defendants

______________________ 

2014-1617, 2014-1619

______________________ 

Appeals from the United States District Court for the 

Southern District of Ohio in No. 1:10-cv-00564-MRB, 

Judge Michael R. Barrett.

______________________ 

ON MOTION

______________________ 
2 LEXMARK INTERNATIONAL, INC. v. IMPRESSION PRODUCTS, INC. 

PER CURIAM.

O R D E R

Amici Curiae Biotechnology Industry Organization

and CropLife International move unopposed to participate 

in the oral argument scheduled for October 2, 2015 and to 

expedite the decision or ruling on the motion to allow 

argument.

Upon consideration thereof, 

 IT IS ORDERED THAT: 

The motions are granted. Amici Curiae, Biotechnology 

Industry Organization, et al. is allotted 5 minutes of the 

30 minutes previously allotted to Lexmark International, 

Inc. Counsel for the amici curiae should docket the Response to Oral Argument Order event, by 3:00 p.m. 

Thursday, September 24, 2015 advising the court of the 

name of the attorney who will present its argument. 

 FOR THE COURT

 September 24, 2015 /s/ Daniel E. O’Toole 

 Date Daniel E. O’Toole

 Clerk of Court
EXHIBIT 4.1

NO.  6                                                         1,010,000  SHARES


                       EUROPE INVESTOR DIRECT.COM LIMITED

                 Incorporated under the Companies Acts, 1985-89

                         Capital - - - - (pound)200,000

              Divided into 20,000,000 ORDINARY SHARES OF 0.01p EACH


This is to Certify  that Pet  Health  Systems,  Inc.  of 4400 Route 9, 2nd Floor
Freehold  NJ07728,  USA is the  Registered  Proprietor  of  1,010,000  shares of
(pound)0.01p  each, in the  above-named  Company,  subject to the Memorandum and
Articles of  Association  of the Company,  and that upon each of such Shares the
sum of (pound)0.01 has been paid.

  Given under the common seal of the above Company, this 24th day of March 2000

OR under the  signatures  of a director and the secretary or  alternatively  two
directors of the company in accordance  with the provision Of section 36A (4) of
the Companies Act 1985, there being no requirement for a common seal.



                                          /s/ FOR AND ON BEHALF OF
                                        JODY ASSOCIATES LIMITED Secretary
                                      ----------------------------------------
Directors

/s/ Illegible
---------------------

NOTE-No  transfer of any of the above-  mentioned shares can be registered until
this Certificate has been deposited at the Company's Registered Office
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet, consolidated statement of operations
and consolidated statement of cash flows included in the Company's Form
10-Q for the period ending May 31, 1998 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          NOV-30-1998
<PERIOD-END>                               MAY-31-1998
<CASH>                                           5,335
<SECURITIES>                                     9,965
<RECEIVABLES>                                   12,021
<ALLOWANCES>                                       542
<INVENTORY>                                          0
<CURRENT-ASSETS>                                29,778
<PP&E>                                           3,948
<DEPRECIATION>                                   1,472
<TOTAL-ASSETS>                                  45,963
<CURRENT-LIABILITIES>                            6,118
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            51
<OTHER-SE>                                      39,229
<TOTAL-LIABILITY-AND-EQUITY>                    45,963
<SALES>                                              0
<TOTAL-REVENUES>                                18,317
<CGS>                                                0
<TOTAL-COSTS>                                    9,830
<OTHER-EXPENSES>                                 8,079
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  53
<INCOME-PRETAX>                                    728
<INCOME-TAX>                                       248
<INCOME-CONTINUING>                                480
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       480
<EPS-PRIMARY>                                     0.10
<EPS-DILUTED>                                     0.08
        


</TABLE>
**BOVIE
MEDICAL CORPORATION**
 
 EXHIBIT 32.2
 
 Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 In
connection with the Annual Report of Bovie Medical Corporation (the “Company”)
on Form 10-KSB for the year ended December 31, 2004 as filed with the Securities
and Exchange Commission on the date hereof, I, Charles Peabody, Chief Financial
Officer, certify, pursuant to 18 USC §1350 as adopted pursuant to section 906 of
the Sarbanes-Oxley Act of 2002, that (1) the Annual Report fully complies with
the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and (2) the information contained in the annual report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.
 
 
 Date:
March 25, 2005
 
 
 
 /s/
      Charles PeabodyChief
      Financial Officer,
 
 
 A signed
original of this written statement required by Section 906 of the Sarbanes-Oxley
Act has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon
request.